ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -2 مورد

Outbreaks in long-term care facilities: Detection and management

Outbreaks in long-term care facilities: Detection and management
Author:
Noleen Bennett, PhD, MPH
Section Editor:
Anthony Harris, MD, MPH
Deputy Editor:
Keri K Hall, MD, MS
Literature review current through: Apr 2025. | This topic last updated: Apr 18, 2025.

INTRODUCTION — 

Long-term care facilities (LTCFs) represent a diverse group of health care settings that serve individuals of all ages and provide variable degrees of care. LTCFs include nursing homes, skilled-nursing facilities providing postacute care, assisted living facilities, retirement homes, rehabilitation centers, long-term care hospitals, long-term psychiatric facilities, and institutions for individuals with intellectual disabilities. For many residents, these facilities are a home as well as a place of nursing, medical, and/or psychosocial care.

This topic will discuss outbreak detection and management in LTCFs [1-4].

The basic principles of infection prevention and control (IPC) in LTCFs are discussed elsewhere. (See "Principles of infection prevention and control in long-term care facilities".)

Medical management of patients with suspected infections in LTCFs is discussed separately. (See "Medical care in skilled nursing facilities (SNFs) in the United States", section on 'Infections'.)

Topic reviews specific to coronavirus disease 2019 (COVID-19) are presented separately. (See "COVID-19: Epidemiology, virology, and prevention" and "COVID-19: Clinical features" and "COVID-19: Diagnosis" and "COVID-19: Infection prevention for persons with SARS-CoV-2 infection".)

SOURCES OF INFECTION — 

Infections are common in residents of LTCFs, especially including respiratory tract infection, gastrointestinal infection, urinary tract infection, and skin and soft tissue infection [5]. Together, these infections represent 94 percent of infections seen in LTCFs [2,3,6,7]. (See "Medical care in skilled nursing facilities (SNFs) in the United States", section on 'Infections'.)

Some types of infection occur within individual patients and do not spread to other patients or cause outbreaks (eg, urinary tract infection, most types of bacterial pneumonia). However, some infections are caused by communicable pathogens, meaning they are capable of transmission from person to person. Certain pathogens can persist for long periods on surfaces or fomites and spread when individuals touch the contaminated item.

Some pathogens that cause outbreaks in LTCFs, especially respiratory viruses, are introduced to the facility from individuals who enter the facility from the community (ie, staff, visitors, or newly admitted residents). Less commonly, pathogens can arise from facility sources (eg, Legionella from water sources) or contaminated food or equipment.

SPREAD OF INFECTION — 

LTCFs have unique features that support the transmission of infections and predispose them to outbreaks. Specifically, the patient population is at especially high risk for developing infection, and the environment provides ample opportunity for spread.

Patient-specific factors — Residents of LTCFs are at higher risk of developing infection after exposure due to their underlying conditions and medical interventions. Specific risk factors include the following:

Underlying medical illness

Incontinence

Depressed mental state

Use of medications that suppress the immune system or the central nervous system

Protracted use of devices such as urinary catheters and nasogastric tubes

Facility-related factors — LTCFs are prone to spread infection due to numerous challenges unique to their environment:

Communal living (including sharing of sanitary bathrooms)

Frequent close contact between residents, staff, and visitors

Frequent transfer of patients between health care facilities, including hospitals [8]

High resident-staff ratios as well as high staff workload and turnover

Inadequate implementation of infection prevention and control (IPC) policies

PREVENTION OF OUTBREAKS — 

Preventing transmission of infection is one of the key pillars of IPC programs within health care facilities, including LTCFs.

The components of an effective infection prevention program are discussed in detail separately. (See "Principles of infection prevention and control in long-term care facilities".)

Not only do these programs prevent infections within LTCFs, but they also prevent spread of infection from LTCFs to the community and hospitals when residents, staff, and visitors leave the LTCF.

DETECTION OF OUTBREAKS — 

An outbreak is defined as an unusual, significant increase in illness above the facility's baseline levels. In many cases, an outbreak is detected by care providers within the facility who notice a cluster of similar illnesses over a short period of time. A change in baseline surveillance data can also provide awareness of an outbreak; surveillance data can be especially helpful for detecting outbreaks when spread is more subtle and occurs over weeks or months.

A cluster of febrile illnesses, respiratory infections, vomiting and/or diarrheal illnesses, or rashes should raise suspicion for an outbreak. Detection of an epidemiologic link (ie, a common exposure or source) between cases further supports the diagnosis of an outbreak as opposed to an unexplained cluster.

For some infections, a single case of health care-acquired infection represents a sentinel event that should be investigated by infection prevention and control (IPC) personnel. An understanding of the incubation period for each illness can help to determine whether the infection was acquired during the health care facility stay or was incubating at the time of admission. Examples of sentinel events include single cases of crusted scabies, legionellosis, invasive group A streptococcal (GAS) infection, influenza, tuberculosis (TB), meningococcal meningitis, bacterial foodborne infection (eg, salmonellosis), bloodborne pathogen (human immunodeficiency virus [HIV], hepatitis B or C), and Candida auris.

If an outbreak is suspected, testing of affected residents should be performed to determine the underlying pathogen. In some cases, the local health department can provide testing and guidance.

MANAGEMENT OF OUTBREAKS

General approach — The approach to managing an outbreak in an LTCF involves early identification of all infected or colonized residents, prompt containment of the infection, and interventions to prevent spread. Outbreaks of respiratory pathogens are managed slightly differently than those due to pathogens that spread by direct or indirect contact or via a common source. (See 'Respiratory pathogens' below and 'Pathogens spread by contact' below.)

Overarching interventions include the following:

Notification of local public health department – Local public health experts can help identify and manage outbreaks in LTCFs. In some of these locales, public health notification is mandatory for certain types of outbreaks.

Development of a case definition and identifying affected individuals – A case definition is used to classify each resident (and staff member, if indicated) as part of the outbreak or not. Cases are often categorized based on the certainty of involvement in the outbreak (eg, definite case versus probable case).

Depending on the pathogen, the case definition may include only those who are symptomatic. In other situations, mass testing may be necessary to identify asymptomatic individuals who are colonized or subclinically infected with the pathogen.

Determination of containment measures – Potential containment measures may include isolation of infected residents, cohorting of infected residents, quarantining exposed residents, and furloughing exposed staff.

Isolation – Isolation involves physically isolating infected residents in private rooms (or housing them in a room with other infected residents), with a designated bathroom if possible, as well as use of transmission-based precautions depending on the pathogen. Some respiratory pathogens require use of a respirator (eg, N95), whereas others require only a well-fitting mask (eg, surgical mask). (See 'Respiratory pathogens' below and 'Pathogens spread by contact' below.)

Cohorting – Cohorting involves placing residents infected with the same pathogen in shared space. This may include sharing rooms or dedicating a section or ward of the LTCF to infected residents. In such situations, dedicated trained staff may be assigned to these areas to prevent spread between infected and uninfected units.

Quarantining – Quarantine is isolation of individuals (residents and staff) who have been exposed to the pathogen and are in the incubation period (ie, they may have acquired the infection but still be asymptomatic). Some pathogens are transmissible prior to onset of symptoms (eg, varicella, COVID-19). Some pathogens can be transmitted to others from colonized or infected individuals who never develop symptoms (eg, group A Streptococcus [GAS], methicillin-resistant Staphylococcus aureus [MRSA]).

Furloughing – Staff members who are infected or have been exposed can be furloughed (instructed to not report to work until they are deemed noninfectious).

Prevention of further spread

Addressing the route of transmission – Each pathogen can be categorized based on the route of transmission.

Preventing spread of respiratory pathogens may involve masking of uninfected residents and staff as well as addressing ventilation issues within the facility.

Preventing spread of nonrespiratory and certain respiratory pathogens may involve extensive environmental cleaning and expanded use of gowning and gloving.

Regardless of the route of transmission, standard infection prevention and control (IPC) precautions should be optimized (eg, hand hygiene).

Treating infected residents and staff – Providing treatment to infected residents and staff prevents further spread of infection and may shorten the period infected residents remain in isolation and staff remain away from work.

Providing prophylaxis and/or vaccination – For some pathogens, prophylaxis with an antimicrobial (eg, antiviral agent) has been shown to reduce the duration of outbreaks and number of involved residents. Prophylaxis may be provided only to exposed residents and staff or to the entire affected area of the facility.

For many outbreaks, vaccination of residents and staff after the onset of an outbreak does not provide rapid enough immunity to abort the outbreak. However, for certain pathogens, vaccination is effective, particularly for outbreaks that are prolonged in nature. Vaccination has the added benefit of preventing future outbreaks caused by the same pathogen.

Restricting visitors – Visitors may be the source of infection or may acquire the infection within the facility and spread it into the community.

Visitor restriction may involve limiting the flow of the visitors within the facility to specific areas or restricting visitation altogether.

Preventing spread to other facilities – Transferring patients between facilities can lead to outbreaks in the receiving facility. If a resident is to be transferred, the receiving facility or service should be informed about the outbreak, regardless of whether the resident being transferred is identified as a case.

Respiratory pathogens — Numerous pathogens, especially respiratory viruses, can cause outbreaks characterized by rapid spread, large numbers of infected residents and staff, and severe illness. Respiratory viruses should be suspected if a cluster occurs of febrile illness with nonproductive cough or shortness of breath with or without myalgia, headache, or nasal congestion. Symptoms of acute respiratory infections are often similar, regardless of the pathogen [9].

For respiratory pathogens, the overall approach to management is similar, but there are some differences among pathogens. (See 'General approach' above.)

Testing all symptomatic patients is imperative to identify the suspected pathogen and to ensure that different pathogens are not circulating at the same time within the facility. For example, coinfections and outbreaks due to influenza and SARS-CoV-2 have been documented [10].

SARS-CoV-2 — COVID-19 caused many outbreaks in LTCFs during the peak of the pandemic and continues to cause outbreaks within facilities. During large community outbreaks, more than 40 percent of COVID-19-related deaths were linked to LTCFs, with figures as high as 80 percent in some resource-abundant countries [11].

The United States Centers for Disease Control and Prevention (CDC) and public health organizations in other countries have issued guidance on management of SARS-CoV-2 outbreaks in health care facilities, including LTCFs [12-16]. This guidance includes the interventions discussed above as well as specific interventions discussed separately. (See 'General approach' above and "COVID-19: General approach to infection prevention in the health care setting".)

During periods of high levels of community transmission, certain measures may be implemented to prevent introduction and spread of COVID-19, including visitor restrictions, universal masking, and screening staff members for symptoms prior to entering the facility [12,17-19].

Influenza — Influenza virus is typically brought into an LTCF by staff or visitors and spreads rapidly among the residents who share rooms and eat in a communal dining room. Seasonal outbreaks affecting residents and staff are common and are associated with substantial morbidity.

The challenges of preventing and controlling influenza outbreaks in these settings are well recognized. In a review of 49 outbreaks, median attack rates were 33 percent in residents and 23 percent in staff [20-22]. Attack rates may be up to 70 percent, and case fatality rates may be more than 10 percent [23]. (See "Seasonal influenza in adults: Clinical manifestations and diagnosis", section on 'Uncomplicated illness'.)

Older adults may have less typical presentations of influenza, and this limits the opportunities for early recognition and treatment [23]. In addition, increased age is a recognized risk factor for serious infection [22]. Having low threshold criteria to trigger testing with rapid diagnostic tests may reduce hospitalization and hospital length of stay [24]. The diagnosis of influenza is discussed separately. (See "Seasonal influenza in adults: Clinical manifestations and diagnosis".)

In addition to the above-described interventions (see 'General approach' above), antiviral prophylaxis (often with oseltamivir) is an important component of management of influenza outbreaks; prophylaxis may be especially important in years of vaccine mismatch [25,26]. Use of antiviral drugs significantly reduces the attack rates of influenza [20,27-30]. Details about the use of antivirals for prophylaxis are discussed elsewhere (table 1). (See "Seasonal influenza in adults: Role of antiviral prophylaxis for prevention".)

Further details of infection prevention and outbreak management of influenza in health care facilities are found separately. (See "Infection control measures for prevention of seasonal influenza".)

Respiratory syncytial virus and other viruses — Respiratory syncytial virus (RSV) can cause severe respiratory illness in patients who are older adults or have significant comorbidities [31]. In a series of hospitalized patients over 60, 18 percent had severe outcomes and 4.7 percent died. Seventeen percent of these cases were in LTCFs. (See "Respiratory syncytial virus infection in adults".)

RSV outbreaks in LTCFs are less common than SARS-CoV-2 or influenza outbreaks. If a respiratory virus outbreak is suspected but SARS-CoV-2 and influenza testing are negative, consideration of additional viral testing, including RSV, should be considered [10].

IPC interventions have been developed, and a vaccine is now available against RSV for adults at higher risk of severe disease, including individuals in LTCFs. (See "Respiratory syncytial virus infection in adults", section on 'Infection control precautions' and "Respiratory syncytial virus infection in adults", section on 'Vaccination'.)

Other viruses known to cause outbreaks in LTCFs include rhinovirus [32]. In a Canadian surveillance study, rhinovirus caused 59 percent of respiratory outbreaks during a six-month period in 2009, and disease was sometimes severe [32].

Legionella — Legionella spp can cause severe bacterial pneumonia with a high mortality rate in patients with comorbidities or older age. (See "Clinical manifestations and diagnosis of Legionella infection".)

A single case of infection due to health care-acquired Legionella spp should prompt investigation in health care facilities, including LTCFs. In many locales, public health officials require notification to allow prompt investigation of the source of infection, which is usually a contaminated water source. (See "Treatment and prevention of Legionella infection", section on 'Prevention of Legionella infections'.)

Most cases of legionellosis in LTCFs or hospitals originate from the facilities' water supply or plumbing, including ice machines. An outbreak within an LTCF in the United States was traced to a local cooling tower that likely dispersed water droplets into the LTCF through the air intake system or open windows [33].

Tuberculosis — Tuberculosis (TB) is known to spread in LTCFs, and infections are more likely to occur in regions with high community rates of TB.

Prevention of TB spread in LTCFs depends primarily on testing for latent TB in residents with past exposure or comorbidities that predispose to reactivation of latent TB. Universal screening for latent TB among individuals in LTCFs was common in the past, but targeted screening now has more support [34-37]. The indications and approach for latent TB infection (LTBI) testing are discussed separately. (See "Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening)".)

If an individual with active pulmonary TB is identified in an LTCF or other health care facility, specific interventions are necessary to prevent spread, including isolation in an airborne isolation room, use of respirators for staff who enter the room, screening of exposed individuals, and prophylaxis for a subset of close contacts. Public health officials should be notified for further guidance and community-based investigation. Extensive guidance for IPC in health care facilities is available [38]. (See "Tuberculosis transmission and control in health care settings".)

Studies published in the 1980s suggested a high rate of TB transmission, new infection, and TB disease among older adults in nursing homes. In one study, disease was observed among 5.9 percent of individuals with skin test conversion in the absence of isoniazid therapy [39]. In addition, cohort studies noted lower rates of disease among those who received isoniazid for treatment of LTBI [40,41]. Subsequent studies have not shown comparable rates of infection or disease among LTCF residents, and the benefits of isoniazid appear more modest (with perhaps greater harm) than initially suggested [42-49].

Pathogens spread by contact — Pathogens spread by contact cause outbreaks in LTCFs, either via direct physical contact between individuals or indirect contact; indirect contact occurs when an uninfected individual touches a surface or fomite that has been contaminated by an infected individual.

Key interventions to control an outbreak due to a pathogen transmitted by contact include the following:

Isolation of infected residents – Contact precautions involve wearing a gown and gloves when entering an infected resident's room and having the resident wear isolation garb if they must leave their room. For patients on contact isolation, disposable or dedicated care equipment (eg, stethoscopes, walkers) can further help to prevent spread.

Ensuring proper hand hygiene – Hand hygiene is among the most important interventions for stopping spread. For some pathogens (eg, Clostridioides difficile, norovirus), alcohol-based hand gels are ineffective, and switching to soap and water is necessary.

Enhanced environmental cleaning and disinfection – Because many of these pathogens persist for prolonged periods on surfaces, special attention must be given to cleaning the environment. In some cases, the disinfectant agent used from cleaning must be changed due to resistance of certain pathogens to standard agents.

Cohorting – In the setting of large outbreaks or outbreaks due to certain highly infectious pathogens, cohorting may be necessary, along with using dedicated trained staff to care for residents in the isolation cohort.

Treating infected residents and staff – If available, treating infected individuals can help curb the outbreak.

Diarrheal infection — Diarrheal illness may spread rapidly in LTCFs and requires a vigorous IPC response for diagnosis and prevention. The most common source of diarrheal outbreaks is an infected individual, although contaminated food can also cause outbreaks.

Residents of LTCFs are estimated to have the highest incidence of diarrhea in resource-abundant countries [50]. In the United States, approximately 0.05 to 2.0 episodes of gastroenteritis per 1000 patient-days occur among LTCF residents [51]. In Australia between 2002 and 2008, 52 percent of gastroenteritis outbreaks occurred in the nursing home settings; 6.4 percent of patients were hospitalized and 2.7 percent died [52]. Older adults are at increased risk of infection in the setting of decreased gastric acid production, and morbidity and mortality are associated with dehydration [53].

Viral gastroenteritis — Norovirus is the most common cause of diarrheal outbreaks in LTCFs. The virus spreads efficiently from person to person, and food contaminated by a food service provider can cause large outbreaks.

LTCFs are the most common setting for norovirus outbreaks in the United States, and the outbreaks are associated with increased mortality [54].

Because the virus is not killed by alcohol-based hand sanitizer, use of soap and water for hand hygiene is necessary; the virus is also resistant to standard cleaning agents, so bleach solutions are commonly used for environmental cleaning. Nearly half of symptomatic patients shed virus for at least 21 days.

Norovirus is discussed in detail separately, and CDC guidance for managing norovirus outbreaks is available [55]. (See "Norovirus".)

Other viral causes of diarrheal outbreaks include rotavirus, adenovirus, and astrovirus. (See "Acute viral gastroenteritis in adults".)

Clostridioides difficile — C. difficile is the most common cause of health care-associated diarrhea in resource-abundant countries; older adults are disproportionately affected [56]. Among nursing home residents treated with antibiotics in the United States, 8 to 33 percent acquire C. difficile infection, and 10 to 30 percent of LTCF residents are colonized [57]. The incidence has more than doubled in recent decades [58,59]. Disease severity has also increased, especially in those over 60 years of age. Nearly one-half of health care-associated C. difficile infection now occurs in LTCFs [59].

Adequate cleaning of LTCF environments, including removal of spores, is particularly difficult. Soap and water are necessary for hand hygiene (instead of alcohol-based hand gels), and bleach solutions are often necessary for environmental cleaning due to resistance to standard disinfectants.

Antibiotic stewardship within LTCFs is important for prevention of C. difficile infections and outbreaks. Patients with active diarrheal infection should be treated, but there is no role for treatment of C. difficile infection in the setting of asymptomatic carriage.

Issues related to prevention of C. difficile infection, including environmental cleaning and hand hygiene, are discussed further separately. (See "Clostridioides difficile infection: Prevention and control".)

Other pathogens — Other causes of foodborne outbreaks include Salmonella, Staphylococcus, and Escherichia coli O157:H7. In an Australian study of older adult residents of LTCFs between 2005 and 2009, the rates of Salmonella infection were higher and the rates of toxigenic E. coli, Campylobacter, and Shigella lower compared with community residents [60].

Additional causes of diarrheal outbreaks in LTCFs include Shigella, Yersinia, Giardia, and Cryptosporidium. (See "Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings".)

Skin and soft tissue infection — Important skin and soft tissue infections that cause outbreaks in LTCFs include infestations (eg, scabies), viral infections (eg, shingles), and fungal infections (eg, tinea) [61,62].

Scabies — Scabies outbreaks can occur in LTCFs [63,64]. Scabies infection is associated with itch and rash (picture 1 and figure 1). Crusted scabies is a severe form of scabies characterized by scaly lesions with an enormous mite load; pruritus is not always present in crusted scabies (picture 2 and picture 3). Due to the enormous mite load, patients with crusted scabies may be the index case in LTCF outbreaks. (See "Scabies: Epidemiology, clinical features, and diagnosis", section on 'Crusted scabies'.)

The diagnosis of scabies should be confirmed by skin scrapings. Delayed diagnosis may occur in more than 10 percent of patients and is associated with chronic steroid use, acquired immunodeficiency syndrome (AIDS), and long hospitalization [65]. (See "Scabies: Epidemiology, clinical features, and diagnosis", section on 'Diagnosis'.)

Residents with scabies should be treated and placed in contact precautions (including shoe covers in cases of crusted scabies); close contacts (including roommates, staff, and family members) should also be empirically treated [66]. (See "Scabies: Management", section on 'Contacts and environment'.)

Shingles — Herpes zoster (shingles) is a common skin infection in LTCFs and occurs when the varicella zoster virus (VZV) reactivates in patients who had primary VZV infection (ie, chickenpox) earlier in life.

Patients with shingles rarely instigate outbreaks because shingles is much less contagious than chickenpox, and many older individuals cannot acquire the virus due to past infection. Furthermore, VZV vaccination is available to nonimmune individuals and has become a standard childhood vaccine in many countries, including the United States. A separate shingles vaccine is also available and is effective in older individuals [67,68].

Small outbreaks have been reported and are usually due to a patient with shingles who also has underlying immunocompromise. Patients who acquire infection from patients with shingles develop primary VZV infection (chickenpox) and should be isolated in airborne/contact isolation; primary VZV is a highly transmissible pathogen.

Prevention of VZV infection in health care facilities is discussed in detail separately. (See "Prevention and control of varicella-zoster virus in health care facilities".)

Tinea infection — Outbreaks of tinea infection can occur and may be perpetuated by contamination of washing areas, linens, or grooming equipment (picture 4). Measures to control these infections should include prompt treatment of infected individuals, environmental cleaning, and surveillance. Antifungal resistance is emerging in tinea infections [69]. (See "Dermatophyte (tinea) infections".)

Conjunctivitis — Conjunctivitis may occur sporadically or in outbreaks and may be caused by bacterial (such as Staphylococcus aureus) or viral (such as adenovirus) pathogens. It is spread by direct contact with an infected person's secretions or a contaminated object. The incidence in LTCF was 0.6 to 3.5 per 1000 patient-days in one report [70]. (See "Infectious conjunctivitis".)

Group A Streptococcus — Outbreaks of group A Streptococcus (GAS) infection in LTCFs have been described [71,72]. In one review including 1762 cases of invasive GAS infection, the incidence among LTCF residents compared with community-based older adults was 41 versus 7 cases per 100,000 population [71]. Patients in LTCFs were 1.5 times as likely to die from the infection as community-based patients (33 versus 21 percent). Outbreaks may occur over a long period of time, be challenging to identify, and can originate from an asymptomatic carrier [73].

Transmission is predominantly person to person, particularly via direct contact between residents. If a single case of invasive GAS occurs in an LTCF resident, an investigation is typically performed. Interventions include contact tracing and potential testing for colonization among certain staff members. Staff who are epidemiologically linked to infected residents may undergo empiric treatment to try to eradicate colonization. The CDC has issued guidance [74], and IPC is discussed in further detail separately. (See "Invasive group A streptococcal infection and toxic shock syndrome: Treatment and prevention", section on 'Prevention'.)

Clinical syndromes due to GAS include cellulitis, toxic shock syndrome, pharyngitis, bronchitis, pneumonia, and bacteremia. These are discussed further separately. (See "Treatment and prevention of streptococcal pharyngitis in adults and children" and "Invasive group A streptococcal infection and toxic shock syndrome: Epidemiology, clinical manifestations, and diagnosis".)

Antimicrobial-resistant organisms — Multidrug-resistant organisms (MDROs) are more common in LTCFs than hospitals in the United States [75-78].

MDROs cause numerous infectious syndromes, including urinary tract infection, pneumonia, wound infections, device-related infections, and bacteremia.

Over 35 percent of United States nursing home residents are colonized with MDROs, and colonization is a major risk factor for subsequent development of an active infection [77,79,80]. Many residents have extensive histories of health care exposure and indwelling devices, both of which are risk factors for MDROs.

The LTCF environment poses challenges to MDRO prevention [78,81,82]. Organisms may be transferred between acute care facilities and LTCFs via LTCF residents, and transmission can occur via contact with colonized skin, fecal-oral transmission, or contaminated surfaces. In addition, there is often considerable antibiotic overuse.

Basic IPC interventions play an integral role to preventing spread of MDROs, especially hand hygiene, patient bathing/cleansing, proper wound and device care, and environmental cleaning and disinfection. A randomized trial has found that universal decolonization of all residents may prevent spread of MDROs [83].

Routine isolation of colonized residents is advocated by some but is often difficult due to the large number of colonized residents in some LTCFs and the prolonged duration of colonization in many patients; prolonged isolation in LTCFs markedly alters the quality of life of affected residents [84].

In the setting of an outbreak, additional interventions may include screening for colonization along with isolation and treatment of colonized residents [84].

Numerous MDROs can spread within LTCFs [80,85-90]; several are detailed below.

Methicillin-resistant Staphylococcus aureus — Approximately 10 to 50 percent of LTCF residents in United States are colonized with methicillin-resistant S. aureus (MRSA); one study including 412 residents reported a MRSA prevalence rate of 58 percent [91]. Risk factors for MRSA colonization in LTCFs include antimicrobial use, dependence on health care personnel for assistance with activities of daily living, presence of decubitus ulcers, and kidney dysfunction [92,93].

Issues related to prevention and control of MRSA are discussed further separately, and guidelines have been published for acute care hospitals [94]. (See "Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Prevention and control".)

Multidrug-resistant gram-negative bacilli — Prevalence of multidrug-resistant gram-negative bacilli is increasing, and LTCFs are a major source of spread [95]. These pathogens are becoming increasingly difficult to treat due to the level of resistance.

Such pathogens include extended-spectrum beta-lactamase-producing bacteria, multidrug-resistant Pseudomonas spp, carbapenem-resistant Enterobacterales, and Acinetobacter baumannii. These organisms are discussed in-depth in dedicated UpToDate topics. (See "Extended-spectrum beta-lactamases" and "Epidemiology, microbiology, and pathogenesis of Pseudomonas aeruginosa infection" and "Carbapenem-resistant E. coli, K. pneumoniae, and other Enterobacterales (CRE)" and "Acinetobacter infection: Epidemiology, microbiology, pathogenesis, clinical features, and diagnosis".)

Residents of LTCFs are at increased risk for acquisition of multidrug-resistant gram-negative bacteria. Risk factors include prior antibiotic use, mechanical ventilation, fecal incontinence, urinary catheterization, older age, cognitive deterioration, and malnutrition [6,85-89,96-100].

In some facilities, colonization rates with these strains are comparable with or higher than colonization rates in acute care hospitals [98,99,101-105]. The use of bundled interventions for prevention of infection due to drug-resistant gram-negative organisms is discussed separately. (See "Principles of infection prevention and control in long-term care facilities", section on 'Bundled interventions'.)

Vancomycin-resistant Enterococcus — The colonization rate of vancomycin-resistant Enterococcus (VRE) in LTCFs is variable. One study including 100 residents of 20 different LTCFs admitted to an acute care hospital noted 45 percent of patients were colonized with VRE on admission [106]. Another study including 1215 LTCF residents noted a VRE carriage rate of 9.6 percent [107].

A meta-analysis of VRE infections in LTCFs found a higher mortality with VRE bloodstream infections compared with those caused by vancomycin-susceptible isolates [90].

Issues related to prevention of VRE infection are discussed further separately. (See "Vancomycin-resistant enterococci: Epidemiology, prevention, and control".)

Candida auris — C. auris is an emerging pathogen of concern. Unlike other Candida spp, C. auris is intrinsically resistant to multiple classes of antifungal agents, spreads efficiently in health care facilities, persists for prolonged periods on surfaces, and is resistant to many standard disinfectants used for environmental cleaning [95,108].

Outbreaks within LTCFs have been reported [109-112]. Major risk factors include mechanical ventilation, tracheostomies, serious underlying medical comorbidities, frequent health care exposure, exposure to broad-spectrum antibiotics or antifungals, and health care devices (eg, feeding tubes, central venous catheters, urinary catheters) [108].

Cases of C. auris are required in some locales to be reported to public health authorities. Guidance for management of outbreaks in health care facilities is available from the CDC [113].

Drug-resistant pneumococcus — Pneumococcal vaccination has led to an overall reduction in the prevalence of invasive pneumococcal infections [114]. However, penicillin-resistant strains persist, and outbreaks within LTCFs have been reported [115]. LTCFs have also been associated with outbreaks of multidrug-resistant pneumococcus, including isolates resistant to ceftriaxone [116,117].

Bloodborne and sexually transmitted pathogens — Transmission of HIV, hepatitis B, and hepatitis C in LTCFs can occur; both bloodborne and sexual transmission have been described.

Outbreaks have been reported in LTCFs as well. In a review of all hepatitis B and C outbreaks reported to the CDC from 2009 to 2019, 19 hepatitis B outbreaks were identified, and 15 (79 percent) were due to improper use of blood glucose monitors [118]. One outbreak of hepatitis C in an LTCF was identified and was associated with podiatry care, phlebotomy, and nail care performed at the facility.

Outbreaks of HIV within nursing homes are extremely rare [119]. Sexual transmission has been documented within LTCFs caring for the severely mentally ill [120].

Prevention of the spread of bloodborne pathogens within facilities is primarily based on proper use of standard precautions with all patients and safe and proper performance of procedures (eg, phlebotomy, injections) and use of medical equipment (eg, glucose monitors). (See "Infection prevention: Precautions for preventing transmission of infection", section on 'Standard precautions' and "Infection control in the outpatient setting", section on 'Safe injection practices'.)

Every facility should have a protocol and staff training for management of health care workers and residents who have a potential bloodborne pathogen exposure, including prompt access to post-exposure prophylactic medication if indicated. (See "Management of health care personnel exposed to HIV" and "Prevention of hepatitis B virus and hepatitis C virus infection among health care providers".)

SOCIETY GUIDELINE LINKS — 

Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Infection control" and "Society guideline links: COVID-19 – Long-term care facilities".)

SUMMARY AND RECOMMENDATIONS

Spread of infection – In long-term care facilities (LTCFs), the patient population is at especially high risk for developing infection, and the environment provides ample opportunity for spread. (See 'Spread of infection' above.)

Detection of outbreaks – An outbreak is defined as an unusual increase in illness above the facility's baseline levels. In many cases, an outbreak is detected by care providers within the facility who notice a cluster of similar illnesses over a short period of time.

If an outbreak is suspected, testing of affected residents should be performed to determine the underlying pathogen. (See 'Detection of outbreaks' above.)

General approach – Overarching interventions for outbreak management include the following (see 'General approach' above):

Notification of local public health department.

Development of a case definition and identifying affected individuals.

Determination of containment measures – Potential containment measures include isolation of infected residents, cohorting of infected residents, quarantining exposed residents, and furloughing exposed staff.

Prevention of further spread – Methods to prevent spread include addressing environmental routes of transmission (eg, air ventilation, environmental cleaning), treating infected residents and staff, providing prophylaxis and/or vaccination, restricting visitors, and notifying transferring facilities.

Outbreaks due to specific pathogens

Respiratory pathogens – Numerous pathogens, especially respiratory viruses, can cause outbreaks characterized by rapid spread, large numbers of infected residents and staff, and severe illness. Respiratory pathogens include SARS-CoV-2, influenza virus, respiratory syncytial virus (RSV), Legionella spp, and Mycobacterium tuberculosis. (See 'Respiratory pathogens' above.)

Pathogens spread by contact – Pathogens spread by contact cause outbreaks via either direct physical contact between individuals or indirect contact; indirect contact occurs when an uninfected individual touches a surface or fomite that has been contaminated by an infected individual. (See 'Pathogens spread by contact' above.)

-Diarrheal infection (eg, viral gastroenteritis, Clostridioides difficile, foodborne bacteria). (See 'Diarrheal infection' above.)

-Skin and soft tissue infection (eg, scabies, shingles, tinea infection, group A Streptococcus [GAS]). (See 'Skin and soft tissue infection' above.)

-Viral conjunctivitis. (See 'Conjunctivitis' above.)

-Antimicrobial-resistant organisms (eg, methicillin-resistant Staphylococcus aureus [MRSA], multidrug-resistant gram-negative bacilli, vancomycin-resistant Enterococcus [VRE], Candida auris). (See 'Antimicrobial-resistant organisms' above.)

Bloodborne pathogens and sexually transmitted diseases (eg, HIV, hepatitis B, hepatitis C) – (See 'Bloodborne and sexually transmitted pathogens' above.)

ACKNOWLEDGMENT — 

The UpToDate editorial staff acknowledges Rhonda Stuart, MD, who contributed to an earlier version of this topic review.

  1. High KP, Bradley SF, Gravenstein S, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:149.
  2. Heudorf U, Boehlcke K, Schade M. Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011. Euro Surveill 2012; 17.
  3. Cotter M, Donlon S, Roche F, et al. Healthcare-associated infection in Irish long-term care facilities: results from the First National Prevalence Study. J Hosp Infect 2012; 80:212.
  4. Smith PW, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol 2008; 29:785.
  5. Montoya A, Mody L. Common infections in nursing homes: a review of current issues and challenges. Aging health 2011; 7:889.
  6. Pop-Vicas A, Mitchell SL, Kandel R, et al. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56:1276.
  7. Engelhart ST, Hanses-Derendorf L, Exner M, Kramer MH. Prospective surveillance for healthcare-associated infections in German nursing home residents. J Hosp Infect 2005; 60:46.
  8. Daker-White G, Panagioti M, Giles S, et al. Beyond the control of the care home: A meta-ethnography of qualitative studies of Infection Prevention and Control in residential and nursing homes for older people. Health Expect 2022; 25:2095.
  9. Communicable Diseases Network Australia National Outbreak Management. Guideline for acute respiratory infection (including COVID-19, influenza, and RSV) in residential aged care homes, Version 2.0. June, 2024. https://www.health.gov.au/sites/default/files/2024-06/national-guideline-for-the-prevention-control-and-public-health-management-of-outbreaks-of-acute-respiratory-infection-in-residential-aged-care-homes.pdf (Accessed on August 16, 2024).
  10. Testing and management considerations for nursing home residents with acute respiratory illness symptoms when SARS-CoV-2 and influenza viruses are co-circulating. Centers for Disease Control and Prevention. https://www.cdc.gov/flu/professionals/diagnosis/testing-management-considerations-nursinghomes.htm (Accessed on June 20, 2024).
  11. Salcher-Konrad M, Jhass A, Naci H, et al. A COVID-19 related mortality and spread of disease in long-term care: a living systematic review of emerging evidence. medRxiv. Available at: https://medrxiv.org/content/10.1101/2020.06.09.20125237v3.full.pdf (Accessed on September 29, 2023).
  12. Infection prevention and control guidance for long-term care facilities in the context of COVID-19. World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/338481/WHO-2019-nCoV-IPC_long_term_care-2021.1-eng.pdf (Accessed on January 11, 2021).
  13. Prevention and Management of COVID-19 in Long-Term Care and Retirement Homes 4th Edition: January 2023. Public Health Ontario. Available at: https://www.publichealthontario.ca/-/media/documents/ncov/ltcrh/2020/06/covid-19-prevention-management-ltcrh.pdf?la=en (Accessed on September 29, 2023).
  14. Interim Guidance for Influenza Outbreak Management in Long-Term Care and Post-Acute Care Facilities. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/flu/professionals/infectioncontrol/ltc-facility-guidance.htm (Accessed on September 29, 2023).
  15. Bloch N, Männer J, Gardiol C, et al. Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings: a systematic literature review. Antimicrob Resist Infect Control 2023; 12:113.
  16. Interim infection prevention and control recommendations for healthcare personnel during the COVID-19 pandemic. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html (Accessed on June 20, 2024).
  17. Arden NH. Control of influenza in the long-term-care facility: a review of established approaches and newer options. Infect Control Hosp Epidemiol 2000; 21:59.
  18. Dooling K, McClung N, Chamberland M, et al. The Advisory Committee on Immunization Practices' Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1857.
  19. Interim infection prevention and control recommendations to prevent SARS-CoV-2 spread in nursing homes. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/long-term-care.html (Accessed on February 28, 2022).
  20. Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review. Influenza Other Respir Viruses 2014; 8:74.
  21. Cheng HY, Chen WC, Chou YJ, et al. Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014. Influenza Other Respir Viruses 2018; 12:287.
  22. Lansbury LE, Brown CS, Nguyen-Van-Tam JS. Influenza in long-term care facilities. Influenza Other Respir Viruses 2017; 11:356.
  23. Pop-Vicas A, Gravenstein S. Influenza in the elderly: a mini-review. Gerontology 2011; 57:397.
  24. Temte JL, Checovich MM, Barlow S, et al. Rapid Detection of Influenza Outbreaks in Long-Term Care Facilities Reduces Emergency Room Visits and Hospitalization: A Randomized Trial. J Am Med Dir Assoc 2023; 24:1904.
  25. Ye M, Jacobs A, Khan MN, et al. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis. BMJ Open 2016; 6:e011686.
  26. Peters PH Jr, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001; 49:1025.
  27. Gravenstein S, Drinka P, Osterweil D, et al. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. J Am Med Dir Assoc 2005; 6:359.
  28. Booy R, Lindley RI, Dwyer DE, et al. Treating and preventing influenza in aged care facilities: a cluster randomised controlled trial. PLoS One 2012; 7:e46509.
  29. Chang YM, Li WC, Huang CT, et al. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. J Hosp Infect 2008; 68:83.
  30. Gorišek Miksić N, Uršič T, Simonović Z, et al. Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches. Infection 2015; 43:73.
  31. Havers FP, Whitaker M, Melgar M, et al. Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus - RSV-NET, 12 States, July 2022-June 2023. MMWR Morb Mortal Wkly Rep 2023; 72:1075.
  32. Longtin J, Marchand-Austin A, Winter AL, et al. Rhinovirus outbreaks in long-term care facilities, Ontario, Canada. Emerg Infect Dis 2010; 16:1463.
  33. Phares CR, Russell E, Thigpen MC, et al. Legionnaires' disease among residents of a long-term care facility: the sentinel event in a community outbreak. Am J Infect Control 2007; 35:319.
  34. Jensen PA, Lambert LA, Iademarco MF, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54:1.
  35. Finucane TE. The American Geriatrics Society statement on two-step PPD testing for nursing home patients on admission. J Am Geriatr Soc 1988; 36:77.
  36. Reddy D, Walker J, White LF, et al. Latent Tuberculosis Infection Testing Practices in Long-Term Care Facilities, Boston, Massachusetts. J Am Geriatr Soc 2017; 65:1145.
  37. Winston CA, Stone ND. Detect to Prevent: Evaluating Testing and Treatment Practices for Latent Tuberculosis Infection in Long-Term Care Facilities. J Am Geriatr Soc 2017; 65:1139.
  38. TB prevention in health care settings. Centers for Disease Control and Prevention. https://www.cdc.gov/tb-healthcare-settings/index.html (Accessed on June 20, 2024).
  39. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985; 312:1483.
  40. Stead WW, To T, Harrison RW, Abraham JH 3rd. Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med 1987; 107:843.
  41. Stead WW. Isoniazid prophylaxis. Ann Intern Med 1981; 95:393.
  42. Verma G, Chuck AW, Jacobs P. Tuberculosis screening for long-term care: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2013; 17:1170.
  43. Smith BM, Schwartzman K, Bartlett G, Menzies D. Adverse events associated with treatment of latent tuberculosis in the general population. CMAJ 2011; 183:E173.
  44. Chan-Yeung M, Chan FH, Cheung AH, et al. Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong. J Am Geriatr Soc 2006; 54:1334.
  45. Borgdorff MW, Nagelkerke NJ, de Haas PE, van Soolingen D. Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. Am J Epidemiol 2001; 154:934.
  46. Naglie G, McArthur M, Simor A, et al. Tuberculosis surveillance practices in long-term care institutions. Infect Control Hosp Epidemiol 1995; 16:148.
  47. Macarthur C, Enarson DA, Fanning EA, et al. Tuberculosis among institutionalized elderly in Alberta, Canada. Int J Epidemiol 1992; 21:1175.
  48. Marchand RS, Tousignant P. [Tuberculosis in aged persons residing in Quebec facilities: are screening and chemoprophylaxis indicated?]. Can J Public Health 1995; 86:238.
  49. Hutton MD, Cauthen GM, Bloch AB. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep 1993; 108:305.
  50. Archbald-Pannone LR, Boone JH, Carman RJ, et al. Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. J Hosp Infect 2014; 88:218.
  51. Jacobson C, Strausbaugh LJ. Incidence and impact of infection in a nursing home care unit. Am J Infect Control 1990; 18:151.
  52. Kirk MD, Fullerton KE, Hall GV, et al. Surveillance for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002-2008. Clin Infect Dis 2010; 51:907.
  53. Frenzen PD. Deaths due to unknown foodborne agents. Emerg Infect Dis 2004; 10:1536.
  54. Costantini VP, Cooper EM, Hardaker HL, et al. Epidemiologic, Virologic, and Host Genetic Factors of Norovirus Outbreaks in Long-term Care Facilities. Clin Infect Dis 2016; 62:1.
  55. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep 2011; 60:1.
  56. Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc 2010; 58:1556.
  57. Makris AT, Gelone S. Clostridium difficile in the long-term care setting. J Am Med Dir Assoc 2007; 8:290.
  58. Zilberberg MD. Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis 2009; 15:122.
  59. Ziakas PD, Joyce N, Zacharioudakis IM, et al. Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study. Medicine (Baltimore) 2016; 95:e4187.
  60. Kirk MD, Gregory J, Lalor K, et al. Foodborne and waterborne infections in elderly community and long-term care facility residents,Victoria, Australia. Emerg Infect Dis 2012; 18:377.
  61. Darjani A, Alizadeh N, Rafiei E, et al. Skin Diseases among the Old Age Residents in a Nursing Home: A Neglected Problem. Dermatol Res Pract 2020; 2020:8849355.
  62. Hahnel E, Blume-Peytavi U, Trojahn C, et al. Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study. BMJ Open 2017; 7:e018283.
  63. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12:26.
  64. Kim DH, Kim Y, Yun SY, et al. Risk factors for scabies in hospital: a systematic review. BMC Infect Dis 2024; 24:353.
  65. Lay CJ, Wang CL, Chuang HY, et al. Risk factors for delayed diagnosis of scabies in hospitalized patients from long-term care facilities. J Clin Med Res 2011; 3:72.
  66. Public health strategies for crusted scabies outbreaks in institutional settings. Centers for Disease Control and Prevention. https://www.cdc.gov/scabies/php/public-health-strategy-crusted/index.html (Accessed on June 21, 2024).
  67. Brisson M, Pellissier JM, Camden S, et al. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia. Hum Vaccin 2008; 4:238.
  68. Senderovich H, Grewal J, Mujtaba M. Herpes zoster vaccination efficacy in the long-term care facility population: a qualitative systematic review. Curr Med Res Opin 2019; 35:1451.
  69. Centers for Disease Control and Prevention. Information for healthcare providers: Emerging ringworm. www.cdc.gov/ringworm/hcp/clinician-brief-resistant-infections/index.html#:~:text=Trichophyton%20indotineae%20(T.,-indotineae)&text=its%20own%20species.-,T.,body)%20and%20difficult%20to%20treat. (Accessed on November 19, 2024).
  70. Boustcha E, Nicolle LE. Conjunctivitis in a long-term care facility. Infect Control Hosp Epidemiol 1995; 16:210.
  71. Thigpen MC, Richards CL Jr, Lynfield R, et al. Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis 2007; 13:1852.
  72. Jordan HT, Richards CL Jr, Burton DC, et al. Group a streptococcal disease in long-term care facilities: descriptive epidemiology and potential control measures. Clin Infect Dis 2007; 45:742.
  73. Pilon PA, Savard N, Aho J, et al. Invasive group A streptococcal infection outbreaks of typeemm118 in a long-term care facility, and of type emm74 in the homeless population, Montréal, Quebec. Can Commun Dis Rep 2019; 45:26.
  74. Group A streptococcus. Centers for Disease Control and Prevention. https://www.cdc.gov/infection-control/hcp/healthcare-personnel-epidemiology-control/group-a-streptococcus.html (Accessed on June 21, 2024).
  75. Rodríguez-Villodres Á, Martín-Gandul C, Peñalva G, et al. Prevalence and Risk Factors for Multidrug-Resistant Organisms Colonization in Long-Term Care Facilities Around the World: A Review. Antibiotics (Basel) 2021; 10.
  76. Mody L, Foxman B, Bradley S, et al. Longitudinal Assessment of Multidrug-Resistant Organisms in Newly Admitted Nursing Facility Patients: Implications for an Evolving Population. Clin Infect Dis 2018; 67:837.
  77. Cassone M, Mody L. Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and Management. Curr Geriatr Rep 2015; 4:87.
  78. Katz MJ, Roghmann MC. Healthcare-associated infections in the elderly: what's new. Curr Opin Infect Dis 2016; 29:388.
  79. Fisch J, Lansing B, Wang L, et al. New acquisition of antibiotic-resistant organisms in skilled nursing facilities. J Clin Microbiol 2012; 50:1698.
  80. Callejón Fernández M, Abreu Rodríguez R, Arias Á, et al. The Impact of MRSA Colonization on Healthcare-Associated Infections in Long-Term Care Facility Residents: A Whole-Genome Sequencing-Based Study. Microorganisms 2023; 11.
  81. Dumyati G, Stone ND, Nace DA, et al. Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing Homes. Curr Infect Dis Rep 2017; 19:18.
  82. Centers for Disease Control and Prevention (CDC). Implementation of personal protective equipement (PPE) in nursing homes to prevent spread of novel or targeted multidrug-resistant organisms (MDROs). https://www.cdc.gov/hai/containment/PPE-Nursing-Homes.html (Accessed on May 13, 2022).
  83. Miller LG, McKinnell JA, Singh RD, et al. Decolonization in Nursing Homes to Prevent Infection and Hospitalization. N Engl J Med 2023; 389:1766.
  84. Centers for Disease Control and Prevention. Implementation of Personal Protective Equipment (PPE) Use in Nursing Homes to Prevent Spread of Multidrug-resistant Organisms (MDROs). https://www.cdc.gov/long-term-care-facilities/hcp/prevent-mdro/ppe.html (Accessed on October 10, 2024).
  85. Harris AD, Pineles L, Johnson JK, et al. Prevalence of Acinetobacter baumannii and Candida auris in Patients Receiving Mechanical Ventilation. JAMA 2023; 330:1769.
  86. da Silva Marques B, Paixão de Sousa Filho W, Felipe Andreolla H, Vizzotto BS. Environmental microbial colistin resistance in an elderly south Brazilian long-term care facility. Int J Environ Health Res 2024; 34:4118.
  87. De Koster S, Xavier BB, Lammens C, et al. One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019. PLoS One 2024; 19:e0298096.
  88. Azzini AM, Be G, Naso L, et al. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting. Front Cell Infect Microbiol 2023; 13:1155320.
  89. Lee J, Sunny S, Nazarian E, et al. Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016-2022. Emerg Infect Dis 2023; 29:1973.
  90. Eichel VM, Last K, Brühwasser C, et al. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis. J Hosp Infect 2023; 141:119.
  91. Stone ND, Lewis DR, Johnson TM 2nd, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of Veterans Affairs long-term care facilities: role of antimicrobial exposure and MRSA acquisition. Infect Control Hosp Epidemiol 2012; 33:551.
  92. Manzur A, Gudiol F. Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect 2009; 15 Suppl 7:26.
  93. Garazi M, Edwards B, Caccavale D, et al. Nursing homes as reservoirs of MRSA: myth or reality? J Am Med Dir Assoc 2009; 10:414.
  94. Popovich KJ, Aureden K, Ham DC, et al. SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 2023; :1.
  95. Proctor DM, Sansom SE, Deming C, et al. Clonal Candida auris and ESKAPE pathogens on the skin of residents of nursing homes. Nature 2025; 639:1016.
  96. O'Fallon E, Kandel R, Schreiber R, D'Agata EM. Acquisition of multidrug-resistant gram-negative bacteria: incidence and risk factors within a long-term care population. Infect Control Hosp Epidemiol 2010; 31:1148.
  97. Tinelli M, Cataldo MA, Mantengoli E, et al. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother 2012; 67:2982.
  98. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57:1246.
  99. Prabaker K, Lin MY, McNally M, et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012; 33:1193.
  100. Del Carmen Valero-Ubierna M, Benavente-Fernández A, Pérez de Rojas J, et al. Social and clinical predictors of perianal colonisation by multidrug-resistant bacteria for geriatric patients in the internal medicine service. Infection 2024; 52:231.
  101. Burgess MJ, Johnson JR, Porter SB, et al. Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli. Open Forum Infect Dis 2015; 2:ofv011.
  102. Han JH, Maslow J, Han X, et al. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities. J Infect Dis 2014; 209:420.
  103. Mortensen E, Trivedi KK, Rosenberg J, et al. Multidrug-resistant Acinetobacter baumannii infection, colonization, and transmission related to a long-term care facility providing subacute care. Infect Control Hosp Epidemiol 2014; 35:406.
  104. Suetens C, Latour K, Kärki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill 2018; 23.
  105. Australian Commission on Safety and Quality in Health Care. AURA 2021: Fourth Australian report on antimicrobial use and resistance in human health. https://www.safetyandquality.gov.au/sites/default/files/2021-09/aura_2021_-_report_-_final_accessible_pdf_-_for_web_publication.pdf (Accessed on April 15, 2022).
  106. Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis 2002; 34:441.
  107. Benenson S, Cohen MJ, Block C, et al. Vancomycin-resistant enterococci in long-term care facilities. Infect Control Hosp Epidemiol 2009; 30:786.
  108. Yune PS, Coe J, Rao M, Lin MY. Candida auris in skilled nursing facilities. Ther Adv Infect Dis 2023; 10:20499361231189958.
  109. Rossow J, Ostrowsky B, Adams E, et al. Factors Associated With Candida auris Colonization and Transmission in Skilled Nursing Facilities With Ventilator Units, New York, 2016-2018. Clin Infect Dis 2021; 72:e753.
  110. Huang X, Welsh RM, Deming C, et al. Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes. mSphere 2021; 6:e0028721.
  111. Pacilli M, Kerins JL, Clegg WJ, et al. Regional Emergence of Candida auris in Chicago and Lessons Learned From Intensive Follow-up at 1 Ventilator-Capable Skilled Nursing Facility. Clin Infect Dis 2020; 71:e718.
  112. Lyman M, Forsberg K, Reuben J, et al. Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities - Texas and the District of Columbia, January-April 2021. MMWR Morb Mortal Wkly Rep 2021; 70:1022.
  113. Infection control guidance: Candida auris. Centers for Disease Control and Prevention. https://www.cdc.gov/candida-auris/hcp/infection-control/index.html (Accessed on June 22, 2024).
  114. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf (Accessed on May 13, 2022).
  115. Esposito S, Leone S, Noviello S, et al. Antibiotic resistance in long-term care facilities. New Microbiol 2007; 30:326.
  116. Choi MJ, Noh JY, Cheong HJ, et al. Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. PLoS One 2019; 14:e0210520.
  117. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338:1861.
  118. Healthcare-associated hepatitis B and C oubreaks (>=2 cases) reported to the Centers for Disease Control and Prevention (CDC) 2008-2019. https://www.cdc.gov/hepatitis/statistics/healthcareoutbreaktable.htm (Accessed on June 22, 2024).
  119. Beltrami EM, Kozak A, Williams IT, et al. Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. Am J Infect Control 2003; 31:168.
  120. Jasuja S, Thompson ND, Peters PJ, et al. Investigation of hepatitis B virus and human immunodeficiency virus transmission among severely mentally ill residents at a long term care facility. PLoS One 2012; 7:e43252.
Topic 3809 Version 38.0

References